Vaccine Immunity Against Pneumococcus in Children With Sickle Cell Disease: A Retrospective Single-center Study
Our findings suggest that a booster vaccination may be necessary 5 years after the completion of the primary pneumococcal vaccination series. Further large-scale prospective studies are required to better define the optimal frequency of booster doses throughout life and to identify individual factors that contribute to the loss of serological protection.
Authors
- Charlie Noble (ORCID: https://orcid.org/0009-0002-1828-2686)
- Laurent Cimasoni
- Veronica Mattiello (ORCID: https://orcid.org/0000-0002-5000-1015)
- Renato Gualtieri (ORCID: https://orcid.org/0000-0001-8164-7284)
- Géraldine Blanchard‐Rohner (ORCID: https://orcid.org/0000-0002-9974-2172)
Institutions
- University of Geneva (CH)
- Faculty (United Kingdom) (GB)
- University Hospital of Geneva (CH)
- Pediatrics and Genetics (US)
- Geneva College (US)
- University of Lausanne (CH)
Publication Details
- Journal
- The Pediatric Infectious Disease Journal
- Published
- 2025-08-29
- DOI
- https://doi.org/10.1097/inf.0000000000004947
- Primary Topic
- Pneumonia and Respiratory Infections
- Type
- article
- Field-Weighted Citation Impact
- 0.00